Back to all mergers

Abbott Laboratories - Exact Sciences

Approved

Stage

Phase 1 - initial assessment

Effective Notification

02/02/2026

End of Determination Period

17/03/2026

Determination Published

24/02/2026 (22 cal / 16 bus. days)

Determination

Approved

Acquirers

Badger Merger Sub I, Inc

10389384

Targets

Exact Sciences Corporation

020478229

Description

Abbott Laboratories (Abbott), via its wholly owned subsidiary Badger Merger Sub I, Inc, proposes to acquired 100% of the shares in Exact Sciences Corporation (Exact Sciences) through an Agreement and Plan of Merger.

Abbott is a global healthcare company, headquartered in the US, active in the provision of diagnostics, medical devices, nutrition, and branded generic pharmaceuticals.

Exact Sciences is a US headquartered company active in the provision of advanced molecular diagnostics, specialising in cancer screening, precision oncology diagnostics, and genetic testing.

The parties both supply oncological diagnostic products in Australia.

Timeline & Events

  • Phase 1 - initial assessment determination: Approved

    24/02/2026

  • Questionnaire - Abbott - Exact Sciences

    02/02/2026

  • Merger notified to ACCC

    02/02/2026